Cardiol Therapeutics Inc.
CRDL
$1.41
$0.032.17%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 16.21M | 21.25M | 11.76M | 17.55M | 21.10M |
Total Receivables | 241.20K | 251.30K | 197.40K | 177.10K | 234.20K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.14M | 504.90K | 836.40K | 1.18M | 1.29M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 17.58M | 22.01M | 12.79M | 18.91M | 22.63M |
|
|||||
Total Current Assets | 17.58M | 22.01M | 12.79M | 18.91M | 22.63M |
Net Property, Plant & Equipment | 127.00K | 135.90K | 176.10K | 192.20K | 221.60K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | 0.00 | 0.00 | 122.80K | 139.80K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 17.71M | 22.15M | 12.97M | 19.23M | 22.99M |
|
|||||
Total Accounts Payable | 5.37M | 4.85M | 5.12M | 6.89M | 6.54M |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 23.80K | 22.90K | 23.50K | 15.90K | 12.20K |
Total Finance Division Other Current Liabilities | -- | -- | 2.70K | 990.60K | 1.51M |
Total Other Current Liabilities | -- | -- | 2.70K | 990.60K | 1.51M |
Total Current Liabilities | 5.39M | 4.87M | 5.15M | 7.90M | 8.06M |
|
|||||
Total Current Liabilities | 5.39M | 4.87M | 5.15M | 7.90M | 8.06M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 81.00K | 87.20K | 99.30K | 104.20K | 111.30K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 5.47M | 4.96M | 5.25M | 8.00M | 8.17M |
|
|||||
Common Stock & APIC | 142.71M | 141.77M | 134.82M | 126.92M | 124.29M |
Retained Earnings | -130.48M | -124.58M | -127.10M | -115.70M | -112.07M |
Treasury Stock & Other | -- | -- | -- | -- | 2.60M |
Total Common Equity | 12.24M | 17.19M | 7.72M | 11.22M | 14.81M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 12.24M | 17.19M | 7.72M | 11.22M | 14.81M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 12.24M | 17.19M | 7.72M | 11.22M | 14.81M |
|